Givaudan SA (GVDNY) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of Givaudan SA $35.84, price $81.11, upside -55.8%, quality 69 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Givaudan SA ADR for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 1, 2026.
How to read this chart
60‑month range $51.34 – $104.90 · fair‑value band $24.50 – $52.54 · the $81.11 price screens above the $35.84 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 1, 2026.
Follow Givaudan SA ADR in your weekly email
Every Wednesday you see whether Givaudan SA ADR is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing.
Show more
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, including dairy drinks, yoghurt, ice cream, chilled desserts, cream cheese, and spreads; snacks; givaudan flavour ingredients; savory, and supplements and nutraceutical products; and biscuits, crackers, and cereals, as well as confectionery products, such as chewing gums, chocolates, and sweets. It operates in Switzerland, Europe, Africa, the Middle East, North America, Latin America, and the Asia Pacific. Givaudan SA was founded in 1796 and is headquartered in Vernier, Switzerland.
Stock analysis
Givaudan SA ADR (GVDNY) currently trades at $81.11, while our model-based Fair Value estimate is $35.84, 55.8% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $40.79 per share, and 0 of the 25 models we run sit above the $81.11 price.
Bear case: the Asset-Based group reads lowest at $7.95, and 25 of the 25 models stay below the price. Evidence for this calculation is high.
Scenario range: $24.50 (bear) to $52.54 (bull), the price of $81.11 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Givaudan SA ADR reported revenue of CHF 7.5B in FY2025 versus CHF 6.7B in FY2021, a compound +2.8%/yr. Reported net income was CHF 1.1B in FY2025, compounding +6.9%/yr from FY2021.
Key figures
Market cap $37.6B · P/E ratio 28.2 · P/S ratio 4.04 · EPS (TTM) $2.88 · Dividend yield 2.3% · Net margin 14.3% · Return on equity 23.4% · Return on assets (EBIT) 10.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).
What moves the price
The share trades about 8% below its 52-week high and 23% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at −56%, GVDNY screens richer than that median.
Fair Value models
Bear $24.50Fair Value $35.84Bull $52.54
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.75/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+0.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+3.4%
Start year 2020 (pandemic). Over 10 years: +5.4% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+9.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+7.6%
Dividend (yield on the price)2.3%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.7.6% vs 5.4%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.16% → 19%
Start year 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+12.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.6%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in CHF, Switzerland: IMF forecast 0.6% a year to 2030, 0.8% from 2016 to 2025) that is about +12.0% a year for the price and +4.0% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (93 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Neutral
Recent news coverage is roughly neutral, about typical for how stocks are covered.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 699 stocks
Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score69 · Top 25%
Fair Value upside−54.5% · Below median
Profitability
Return on equity (TTM)23.4% · Top 25%
Return on assets7.1% · Top 25%
Net margin (TTM)14.3% · Top 25%
Operating margin (TTM)16.9% · Top 25%
Growth and dividend
Revenue growth−1.8% · Bottom 25%
Dividend yield (TTM)2.3% · Above median
Balance sheet
Debt / equity0.92× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/E (TTM)28.2× · Pricier than median
P/B6.82× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM)4.14× · Priciest 25%
P/FCF25.6× · Pricier than median
EV/EBITDA21.2× · Priciest 25%
PEG4.61× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 56
PAST (return on equity)94· sector 25
HEALTH (low debt)54· sector 95
DIVIDEND (yield)46· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Givaudan SA ADR Fair Value". https://www.fairvalue-calculator.com/stock/GVDNY
Frequently asked questions
Is Givaudan SA (GVDNY) overvalued or undervalued?
As of Oct 1, 2026, our model estimates a fair value of $35.84 versus a price of $81.11, about −56% upside (overvalued).
What is the fair value of GVDNY?
Our model-based fair value for Givaudan SA ADR is $35.84 (as of Oct 1, 2026), built from audited fundamentals. The current price: $81.11.
What is the quality score of GVDNY?
Givaudan SA ADR has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Givaudan SA (GVDNY)?
Our model-based price target is the fair value of $35.84 (as of Oct 1, 2026) from 25 valuation models. Cautious scenario $24.50, optimistic scenario $52.54. It is a calculation from audited fundamentals, not an analyst target.
What is the Givaudan SA ADR stock forecast for 2026?
Our models put fair value at $35.84, about −56% upside versus a price of $81.11 (overvalued). Cautious scenario $24.50, optimistic scenario $52.54. The calculation is refreshed regularly with new filings.
What is the revenue of Givaudan SA (GVDNY)?
Givaudan SA ADR reported trailing-twelve-month revenue of about CHF 7.5B (latest available figure, as of Oct 1, 2026).
Does Givaudan SA ADR pay a dividend?
Givaudan SA ADR currently shows a dividend yield of about 2.28% relative to its recent price (as of Oct 1, 2026).
What growth is priced into Givaudan SA (GVDNY)?
For today's price to be fair in a discounted-cash-flow model, Givaudan SA ADR would have to grow free cash flow by +12.7 % per year for five years (discount rate 8.5 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +3.4 % per year. As of Oct 1, 2026.
What discount rate (WACC) does the fair value of GVDNY use?
Our models discount Givaudan SA ADR at 8.5 %: a base by market capitalisation (large), damped by beta 0.66, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Givaudan SA ADR that is +12.7 % per year a year over ten years, using the same discount rate (8.5 %) and the same formula as our fair value.
How much growth has Givaudan SA (GVDNY) delivered so far?
Over the past 5 years revenue at Givaudan SA ADR grew +3.4 % a year. The price currently implies +12.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Givaudan SA (GVDNY) growing?
The median revenue growth in the sector is +7.8 % a year. That is the yardstick for the growth priced into Givaudan SA ADR (+12.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Givaudan SA (GVDNY)?
The free-cash-flow yield on the price is 3.87 %: that much free cash flow Givaudan SA ADR produces per unit of market value. When it exceeds the discount rate of our models (8.5 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Givaudan SA (GVDNY)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Givaudan SA ADR it is $35.84 per share (as of Oct 1, 2026), against a price of $81.11. It is the blended result of 25 valuation models (cash flow, earnings, asset, dividend).
Is Givaudan SA ADR stock overvalued or undervalued in 2026?
As of Oct 1, 2026, GVDNY trades above its calculated fair value: price $81.11, fair value $35.84, a gap of about −56% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GVDNY?
No. The price is what the market pays today ($81.11); the fair value is what the company's own numbers justify ($35.84). For Givaudan SA ADR the two are $45.27 per share apart. That gap is exactly why we show both numbers side by side.
How much is Givaudan SA ADR worth?
The market values Givaudan SA ADR at about $37.6B (market capitalisation, as of Oct 1, 2026). Per share that is $81.11; our models calculate a fair value of $35.84 per share.
What do the bullish and bearish scenarios say about GVDNY?
Our models span a range for Givaudan SA ADR: cautious scenario $24.50, base $35.84, optimistic $52.54 per share (as of Oct 1, 2026, price $81.11). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GVDNY?
Givaudan SA ADR trades at a price-to-earnings ratio of 28.2 (as of Oct 1, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $35.84 is built from several models across several years. Other multiples: PEG 4.6, P/B 6.8, P/S 4.1, EV/EBITDA 21.2.
What is the PEG ratio of GVDNY?
The PEG ratio of Givaudan SA ADR is 4.61 (P/E divided by earnings growth, as of Oct 1, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Givaudan SA (GVDNY)?
Balance-sheet figures for Givaudan SA ADR (as of Oct 1, 2026): return on equity 23.4%, debt of 0.92 per unit of equity. They feed the Quality Score of 69/100, which measures business quality independently of the share price.
How far is GVDNY from its 52-week high?
Givaudan SA ADR trades at $81.11, about 8% below its 52-week high of $87.74 and 23% above the low of $66.08 (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of $35.84 is for.
Which stocks are comparable to Givaudan SA ADR?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Givaudan SA ADR stock attractive at the current price?
The data as of Oct 1, 2026: price $81.11, calculated fair value $35.84 (−56%), Quality Score 69/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GVDNY calculated?
We run Givaudan SA ADR through 25 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $35.84, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Givaudan SA ADR itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Givaudan SA (GVDNY)?
The closing price on Oct 2, 2026 was $81.11. Our model-based fair value is $35.84, about −56% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Givaudan SA ADR right now?
The price sits above even our optimistic bull case ($52.54). The favourable scenario is already priced in. Solid but not exceptional quality (69/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($24.50 to $52.54) leaves room in how you read the outcome.
Where does the earnings growth of Givaudan SA (GVDNY) come from?
Earnings per share at Givaudan SA ADR grew +5.8 % a year from 2014 to 2025. Broken into its drivers: revenue per share +5.6 %, EBIT margin +0.6 %, tax rate +0.0 %, residual (interest, one-offs) −0.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Givaudan SA ADR
How large is the market capitalisation of Givaudan SA (GVDNY)?
The market capitalisation of Givaudan SA ADR is $37.6B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Givaudan SA (GVDNY)?
The price-to-sales ratio of Givaudan SA ADR is 4.04 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Givaudan SA (GVDNY)?
Earnings per share at Givaudan SA ADR are $2.88 (price ÷ EPS = P/E 28.2). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Givaudan SA (GVDNY)?
The dividend yield of Givaudan SA ADR is 2.3% (payout 64.2%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Givaudan SA (GVDNY)?
The net margin of Givaudan SA ADR is 14.3% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Givaudan SA (GVDNY)?
The return on equity (ROE) of Givaudan SA ADR is 23.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Givaudan SA (GVDNY)?
On an EBIT basis the return on assets of Givaudan SA ADR is 10.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Givaudan SA (GVDNY)?
The operating margin of Givaudan SA ADR is 16.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Givaudan SA (GVDNY)?
Revenue at Givaudan SA ADR is growing −1.8% versus a year earlier (3y avg +1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Givaudan SA (GVDNY)?
Earnings per share at Givaudan SA ADR are growing −4.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Givaudan SA (GVDNY) carry?
The net debt of Givaudan SA ADR is CHF 3.7B (fiscal year 2025, ≈ 3.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Givaudan SA ADR in the live analysis
One click puts Givaudan SA ADR on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Broad data
Oct 1, 2026